Pharmacy Times

MAY 10, 2023

An FDA committee voted 17-0 to make the once-daily birth control medication Opill available OTC after deciding the benefits outweigh any potential harms.

FDA 139

FDA 139

Drug Store News

OCTOBER 23, 2023

GNC Health now offers low cost virtual health care for urgent conditions, primary care appointments, mental health, physical therapy, $0 prescription medications and more.

110

110

STAT

MAY 16, 2024

The bill passed to the full committee unanimously on a 21-0 vote. Originally, the House Energy and Commerce health subcommittee had considered a bill that would have enacted the policies permanently, but amended the legislation Thursday to pare it down to a two-year extension. Read the rest…

71

71

Pharmacy Times

AUGUST 4, 2023

CDC Advisory Committee on Immunization Practices voted 10 to 0 to recommend the routine use of nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants.

Immunization 123

Immunization 123

STAT

JUNE 1, 2023

But as an addiction medicine specialist, there are figures that give me hope: one seminal study showed that 75% of patients who were given the FDA-approved medication buprenorphine to treat opioid use disorder daily for 12 months remained in recovery — compared with 0% who did not receive buprenorphine treatment for the entire 12 months.

FDA 100

FDA 100

Drug Store News

OCTOBER 2, 2023

The Medicare Plus Blue PPO + Meijer plan features a $0 monthly premium and $660 annual allowance to spend in Meijer stores.

111

111

Fierce Pharma

SEPTEMBER 13, 2023

But on Tuesday, an FDA advisory committee agreed by a 16-0 vote that the ingredient does not work. . | For decades, hundreds of oral decongestant products containing phenylephrine have been available in the United States over the counter.

FDA 120

FDA 120

Fierce Healthcare

APRIL 8, 2024

Enrollees in Medicare Advantage (MA) plans with no monthly premiums are three times more likely to be nonwhite compared to traditional Medicare counterparts, research from Harvard Medical School an | In Medicare Advantage plans with $0 monthly premiums, enrollees are three times as likely to be nonwhite, research from Harvard and Inovalon shows.

Medical Schools 62

Medical Schools 62

STAT

MARCH 15, 2024

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment.

FDA 126

FDA 126

Drug Store News

FEBRUARY 1, 2024

Made with 0 g of caffeine, the product contains 996 mg of electrolytes and is formulated to help replenish the five electrolytes lost in sweat, the company said.

52

52

STAT

AUGUST 3, 2023

The 10-0 recommendation from the Advisory Committee on Immunization Practices now goes to CDC Director Mandy Cohen, who is expected to accept it. Read the rest…

Immunization 96

Immunization Hospitals 96

Hospital Pharmacy Europe

APRIL 24, 2023

Median overall survival was 12·7 months with pembrolizumab plus chemotherapy and 10·9 months in the placebo group (hazard ratio, HR = 0·83, 95% CI 0·72 – 0·95, p = 0.0034). Pembrolizumab plus chemotherapy and overall survival There were 1069 participants of whom, 533 had pembrolizumab followed for 25.6

Chemotherapy 98

Chemotherapy Hospitals 98

Fierce Healthcare

MAY 31, 2023

Hospitals’ year-to-date operations broke even in April, though a rise in bad debt and a dip in volumes suggest the upward momentum will likely be short-lived, healthcare consulting firm Kaufman Hal | Kaufman Hall's latest monthly industry report showed a 0% year-to-date median operating margin across the hospital industry as well as signs of bad (..)

Hospitals 107

Hospitals 107

STAT

NOVEMBER 8, 2023

The package passed the committee 26-0 with no amendments added. WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications. Ron Johnson (R-Wis.)

Packaging 111

Packaging Hospitals Insurance 111

Drug Store News

SEPTEMBER 20, 2022

Fi-Being, available in passion fruit and elderberry flavors, contains 11 g of dietary fiber, 4 g of sugar and 0 g of sugar alcohol, the brand said.

95

95

STAT

JUNE 9, 2023

The group voted 6-0 that an 1,800-patient study of Leqembi confirmed its benefits for patients in the early stages of Alzheimer’s, recommending the FDA widen the drug’s limited approval.

FDA 140

FDA Hospitals 140

STAT

MAY 18, 2023

The Vaccines and Related Biological Products Advisory Committee voted 14-0 that Pfizer’s data showed the vaccine was effective in preventing severe disease in infants born to people who were vaccinated during pregnancy.

Vaccines 98

Vaccines FDA Immunization 98

PharmaShots

MARCH 20, 2023

The study met its 1EPs & 2EPs i.e., patients treated with TAK-279 (5/15/30mg, qd) achieved PASI 75 (44%/68%/67% vs 6%), PASI 90 (21%/45%/46% vs 0%) and PASI 100 (10%/15%/33% vs 0%), PGA scores of 0/1 (27%/49%/52% vs 4% or 0 (10%/15%/33% vs 0% at 30mg), respectively @12wks.

40

40

Pharmaceutical Technology

SEPTEMBER 12, 2022

The percentage of subjects attaining Psoriasis Area and Severity Index (PASI) 75 as well as static Physician’s Global Assessment score of 0 or 1 (sPGA 0/1) at week 16 compared to placebo were the co-primary endpoints of the trials. According to the findings, Sotyktu was found to have superior efficacy versus placebo and Otezla.

FDA 98

FDA 98

European Pharmaceutical Review

DECEMBER 15, 2022

The primary endpoint in both trials evaluated the proportion of patients with clinically meaningful improvement in itch from baseline (measured by a ≥4-point reduction in Worst-Itch Numeric Rating Scale [WI-NRS] on a 0-10 scale) at 24 and 12 weeks, respectively.

Hospitals 80

Hospitals 80

Drug Store News

NOVEMBER 9, 2023

The Senate Finance Committee advanced the legislation on a strong bipartisan vote of 26-0, with one ‘present.’

52

52

Drug Store News

NOVEMBER 2, 2023

The Zero Sugar Juice Drinks feature 0 g of sugar and come in two flavors—cranberry and mixed berry, the brand noted.

52

52

STAT

MAY 10, 2023

It voted 17-to-0 in favor of making the pill accessible over the counter; the FDA is expected to make a final decision this summer. Read the rest…

FDA 106

FDA 106

STAT

MARCH 22, 2023

By a 9-0 vote, the FDA advisory panel said the “totality of the evidence” was sufficient to support conditional approval of the Biogen drug, called tofersen.

FDA 92

FDA 92

European Pharmaceutical Review

OCTOBER 6, 2023

This was the case for all four influenza vaccine strains GMT ratios of mRNA-1083 relative to Spikevax bivalent were > 9 in adults between 50 and 64 years old and > 1.0 in adults 65 to 79 years of age, relative to Spikevax.

Vaccines 95

Vaccines Pharmaceutical Companies Pharmaceutical Companies 95

European Pharmaceutical Review

DECEMBER 6, 2023

percent of anti-C5-experienced Fabhalta patients responded versus 0 percent for anti-C5. percent of anti-C5-experienced Fabhalta patients who responded compared to 0 percent for anti-C5. percent of complement inhibitor-naïve patients using Fabhalta achieved this outcome. percent for anti-C5-experienced Fabhalta patients versus 45.7

FDA 84

FDA 84

Fuld

APRIL 21, 2023

Our workshops are an advanced approach to Ba 100 90016 0 90016 0 0 27377 0 --:--:-- 0:00:03 --:--:-- 27385 ttle Cards.

Communication 52

Communication 52

Hospital Pharmacy Europe

MARCH 6, 2023

Symptom severity was assessed using the Sino-Nasal Outcome Test (SNOT-22), a patient-reported outcome measure which assesses 22 symptoms, each of which were assessed at baseline and after one week, using a 0 to 5 scale, where 0 = no problem and 5 = ‘problem as bad as can be’ Essential oil nasal spray and SNOT-22 score A total of 18 subjects (..)

Documentation 98

Documentation Hospitals 98

STAT

SEPTEMBER 6, 2022

The feature, called Halo Movement Health, generates an overall score from 0 to 100, identifies weak points in people’s mobility, stability, and posture, and suggests simple exercises to improve them. Continue to STAT+ to read the full story…

90

90

Pharmaceutical Technology

JULY 26, 2022

of total fintech jobs - up from 0% in the same quarter last year. The fastest growing country was the United States, which saw 0% of all fintech job adverts in the three months ending May 2021, increasing to 9.1% percentage points), China (0), and Belgium (-34.9). The number of roles in North America made up 18.2%

59

59

Hospital Pharmacy Europe

JULY 18, 2023

The study also included a validated Investigator Global Assessment of Atopic Dermatitis (vIGA-AD) score of 0/1 (i.e. of these patients achieved vIGA-AD score of 0 or 1 compared to 15.1% clear or almost clear). In addition, 34.1% of eblasakimab patients receiving the 600 mg dose, achieved an EASI90, compared to only 10.1%

Hospitals 98

Hospitals 98

Hospital Pharmacy Europe

APRIL 26, 2023

The primary endpoint was an Investigator’s Global Assessment (IGA) score of 0 or 1 (clear/almost clear) at week 16. At week 16, significantly more patients receiving TK had an IGA of 0 or 1 than placebo: 21.4% (150 mg) and 17.5% (300 mg) vs 4.3% An alternative was a 75% or higher improvement in EASI (i.e., an EASI 75).

Hospitals 52

Hospitals 52

STAT

APRIL 26, 2024

Deals were made with the manufacturers as well as its distributor Quallent to bring the out-of-pocket cost down to $0. Cigna said it will stock high- and low-concentration versions from Boehringer Ingelheim, Teva Pharmaceutical, and Alvotech, which will be priced at about 85% lower than the $6,922.62 monthly list price of Humira.

Specialty Pharmacies 98

Specialty Pharmacies Hospitals 98

The FDA Law Blog

OCTOBER 27, 2022

Additional examples of modifications to an approved CP that must be submitted as either a CBE-30 or CBE-0 were also provided in the updated guidance. FDA added examples in Section V of the guidance of modifications to an approved CP that must be submitted as an annual report.

FDA 105

FDA Documentation 105

Hospital Pharmacy Europe

OCTOBER 19, 2022

The tool has values ranging from 0 to 10 with lower values indicative of a larger area of infarction. The mRS ranges from 0 to 6 with lower scores indicating less impairment and the primary outcome was set as a mRS score of 0 to 3 at 90 days after the onset of the stroke. In patients with ASPECTS 3 or less, 21.4%

Hospitals 52

Hospitals 52

Hospital Pharmacy Europe

MARCH 29, 2023

The primary outcome was based on an Investigator’s Global Assessment (IGA) score of 0 or 1 (indicating clear (0) or almost clear (1)), with a reduction of at least 2 points from baseline and was assessed after 16 weeks.

Hospitals 96

Hospitals 96

STAT

OCTOBER 31, 2022

A committee of advisers agreed, voting 16-0 to recommend rejecting the drug. But that study had no control group, and the agency and the company disagreed sharply on whether it showed patients were really living longer than standard of care. Continue to STAT+ to read the full story…

FDA 78

FDA 78